Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIOT

Biotech Acquisition (BIOT)

Biotech Acquisition Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOT
DateTimeSourceHeadlineSymbolCompany
02/14/20234:02PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:BIOTBiotech Acquisition Company
02/13/20231:12PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOTBiotech Acquisition Company
02/02/20233:56PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BIOTBiotech Acquisition Company
02/02/20235:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
01/27/202312:19PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOTBiotech Acquisition Company
01/25/202311:14AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOTBiotech Acquisition Company
01/11/20238:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
01/04/20234:51PMPR Newswire (US)Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension AmendmentNASDAQ:BIOTBiotech Acquisition Company
01/04/20232:20PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOTBiotech Acquisition Company
11/22/20225:05AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOTBiotech Acquisition Company
11/14/202212:44PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BIOTBiotech Acquisition Company
10/11/20223:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
08/22/20223:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOTBiotech Acquisition Company
08/01/20227:00AMBusiness WireBlade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology ConferenceNASDAQ:BIOTBiotech Acquisition Company
06/17/20223:06PMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:BIOTBiotech Acquisition Company
06/17/20223:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
06/13/20227:06AMPR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination AgreementNASDAQ:BIOTBiotech Acquisition Company
06/03/20225:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
06/03/20225:03AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
06/02/20227:58PMPR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business CombinationNASDAQ:BIOTBiotech Acquisition Company
05/31/20227:18AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
05/31/20227:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
05/31/20226:30AMPR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business CombinationNASDAQ:BIOTBiotech Acquisition Company
05/24/20228:30AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
05/24/20228:13AMPR Newswire (US)Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.NASDAQ:BIOTBiotech Acquisition Company
05/23/20223:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
05/19/20223:31PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
05/18/20223:21PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
05/18/20223:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
05/18/20228:01AMBusiness WireBlade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International ConferenceNASDAQ:BIOTBiotech Acquisition Company
 Showing the most relevant articles for your search:NASDAQ:BIOT